Stay on the Frontiers of Medicine.
Not finding what you're looking for? Articles from older issues of Proto can be found
MGH’s clinical research center, opened in 1925, created a model for the NIH to open similar facilities across the country.
Peter L. Slavin and David F. Torchiana on the value of reproducing research.
MGH’s pioneering telestroke network brings virtual consultations to outlying hospitals
Nobel Laureate Jack Szostak discusses how research on chromosomes led to current investigations into Earth's first organisms.
The connection between aspirin use and a reduced risk for certain cancers is becoming clearer. MGH researcher Andrew Chan outlines who stands to benefit most.
The storied award from MGH goes to a molecular biologist breaking new ground in cancer genetics.
An MGH program in South Africa partners with young women to research the earliest phase of HIV infection.
Families of returning veterans sometimes develop mental health problems of their own. An MGH team studies the problem and looks for solutions.
A new micro-imaging “pill” lets doctors peer inside the esophagus and beyond.
The Oscar-nominated film puts Alzheimer’s front and center. An MGH social worker talks about the disease behind the story.
MGH tests new waters with its pioneer program for “complex” patients.
Facebook made sure that the world knew about ALS. Now what?
In this video, MGH researcher Alessio Fasano distills fact from fiction in the gluten wars.
Edward Hoffer explains the revolution that DXplain helped to build.
The QPID system uses artificial intelligence to wade through chart data, helping doctors diagnose and treat patients.
In this video, Mass General physician Suzanne Koven discusses the power of personal stories inspired by illness.
In this video, MGH oncologist Karen Winkfield illuminates the past, present, and future of U.S. health disparities
Three months after the last major earthquake in Nepal, two emergency responders from MGH describe the practicalities of delivering care in a disaster zone.
Scientific funding has hit a long rough patch. The director of the MGH Research Institute explores alternative ways to provide sustainable and rewarding careers for the next generation of scientists.
Nobel laureate Jack Szostak reflects on the future of science in the United States.
Ernest Amory Codman, a pioneer in medical quality assessment, made his stand with a cartoon in 1915. It did not end well.
MGH president Peter Slavin discusses racial disparities at the annual meeting of the Association of American Medical Colleges.
The first issue of Proto looked at the genetic roots of mental illness. What’s happened since then?
The first issue of Proto looked at the promise of transplanting organs from other species. What’s happened since then?
Most patients don’t take their daily medications every day. The technology behind a once-a-month pill could save them from themselves.
The first issue of Proto looked at comfort care for those with grave illnesses. The field of palliative care has since grown by leaps and bounds.
Neurologist Lee Schwamm looks at 10 pivotal years in the treatment of stroke victims.
Infectious disease specialist Martin Hirsch looks at the worry over H5N1 and its aftermath.
Although nitric oxide helps relieve certain lung conditions, it is expensive and cumbersome to use. A new invention produces the substance from thin air.
Peter L. Slavin and Thomas J. Lynch Jr. weigh in on the promise and challenge of adopting new technologies in hospitals.
The health care system still delivers poorer care, on average, to African American patients. What can be done?
An artist and physician team up to examine the role of acting in the clinical setting
Medical images are the next frontier for the data revolution, and a new research center plans on taking a closer look.
Peter L. Slavin and Thomas J. Lynch Jr. discuss the role of clinicians in promoting health beyond the hospital.
New therapies for stroke, multiple sclerosis and other conditions may get a boost from interhospital cooperation.
Peter L. Slavin & Thomas J. Lynch Jr. discuss the growing "open data" movement and its implications for scientific research
The Food and Drug Administration tries a fresh approach to medical devices suspected of falling short.
Peter L. Slavin and Thomas J. Lynch Jr. discuss the hospital’s responsibility in treating opioid addiction.
Restless legs syndrome continues to puzzle, even with the recent publication of the first clinical guidelines for the disease.
A new, nationwide team of experts gives the toughest medical cases a chance at a breakthrough.
Atheendar Venkataramani explores the detrimental effects that immigration policy can have on the mental health of undocumented immigrants.